In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
484 News Items found
Pictured: PET Scan
In the Lab
New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment

Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
microscope image of regulatory T cells
MSK Researchers Solve a Key Colorectal Cancer Mystery

A new MSK study finds that in colorectal cancer, not all regulatory T cells are created equal. One subtype suppresses cancer growth while another aids it. The findings could help improve immunotherapy treatment for the majority of patients with colorectal cancer, and potentially for other cancers.
Doctor standing in front of a rainbow flag
Advocacy
Out in Front: Scientists and Activists Call for Recognition of LGBT Cancer Risks

How does being lesbian, gay, bisexual, or transgender affect your risk of getting cancer? Good question.
Memorial Sloan Kettering physician-scientist Vinod Balachandran.
Taking Aim at Pancreatic Cancer: Reasons to Be Optimistic

MSK researchers are making important inroads in understanding and treating pancreatic cancer.
Karuna Ganesh
Feature
The Convergence: Scientists Move toward a New Understanding of Metastatic Cancer

Through converging lines of research in stem cell biology, tissue regeneration, and immunity, Sloan Kettering Institute scientists are learning what makes metastatic cancer cells tick.
Pictured: Activated macrophage
In the Lab
Researchers Reveal How Tumors Manipulate Certain Immune Cells to Their Own Advantage

Researchers are exploring a mysterious population of immune cells that live within tumors and can help the cancer grow and spread.
scan of mouse blood vessel
In the Lab
Surprising Discovery Connects Rare Vascular Disease to Cancer Gene

Researchers found that a common cancer gene called PIK3CA also causes the condition venous malformation. Their discovery has already pointed the way to targeted therapies for this rare and painful condition that affects one in 10,000 people.
Tumor mutation model
Finding
Tumor Mutational Burden Can Help Predict Response to Immunotherapy in Many Different Cancers

Investigators confirmed that people whose tumors have a high tumor mutational burden and were treated with immunotherapy lived longer.
Zsofia Stadler
Finding
Knowledge of Inherited Gene Mutations Increasingly Can Guide Cancer Treatment

An analysis of patients who received molecular testing at MSK has found that about half of those with hereditary gene mutations could benefit from treatment with therapies that target those alterations.
Harold Varmus former CEO of MSK
Harold Varmus: A Decade of Leadership at MSK

Harold Varmus became President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center on January 1, 2000. He ended his decade-long tenure on July 1, 2010. And on July 12, 2010, Dr. Varmus took up a new role as Director of the National Cancer Institute.